RECURRENT THYMOMA

Clinical trials for RECURRENT THYMOMA explained in plain language.

Never miss a new study

Get alerted when new RECURRENT THYMOMA trials appear

Sign up with your email to follow new studies for RECURRENT THYMOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

Experimental drug targets rare thymus cancers after chemotherapy fails

Disease control Ongoing

This phase II trial tests bintrafusp alfa (M7824) in 9 adults with thymoma or thymic carcinoma that returned after platinum-based chemotherapy. Participants receive the drug intravenously every two weeks until their disease worsens or side effects become intolerable. The study ai…

Matched conditions: RECURRENT THYMOMA

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Jun 27, 2026 14:00 UTC

RECURRENT THYMOMA

Get alerted when new RECURRENT THYMOMA trials appear

Experimental drug targets rare thymus cancers after chemotherapy fails